Wright U.S. Recon Sales Falter, But Firm Has High Hopes For Evolution Knee
This article was originally published in The Gray Sheet
Executive Summary
Wright Medical is looking to its newly launched, next generation Evolution medial-pivot primary knee system to help restore domestic reconstructive sales to growth, the firm said during an Aug. 2 second-quarter earnings call
You may also be interested in...
Hip, Knee Sales Growth Slows In Second Quarter For Top Orthopedic Firms
Overall weakness in the hip-and-knee market resulted in low-single-digit reconstructive sales growth for Zimmer, Stryker and Johnson & Johnson/DePuy in the second quarter
With PMA Approval, Wright's Conserve Plus Hip System Resurfaces
FDA approved Wright Medical's Conserve Plus hip resurfacing system, the firm announced Nov. 9, six years after the product's PMA application was originally submitted
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.